9-Me-BC

guinea pig

Also seen as: 9-Methyl-b-carboline

The Dose Guy’s verdict

Sep 1, 2026
3 sources

Interesting mechanism, zero human data, and a safety question that matters. 9-Me-BC has a genuine dopaminergic story in cell cultures and rats, and the neurohacker community runs it for dopamine recovery after stimulant burnout. But nobody has studied what it does in a person, nobody has studied what it does to a person, and the beta-carboline backbone carries a genotoxicity question that UV exposure could make worse. If dopamine support is the goal, bromantane has clinical history and semax has human dosing behind it. 9-Me-BC has neither.

Would I take it?Not with this evidence base.

What it is

A beta-carboline, a family of alkaloids found in trace amounts in the brain and in certain foods. 9-Me-BC is the methylated version that caught the nootropic community’s attention for its effect on dopamine neurons. The pitch is dopamine restoration, the idea that you can rebuild a dopamine system ground down by stimulants, stress, or age. That idea rests entirely on dishes and one rat study.

The safety question is structural, not speculative. The photogenotoxicity work on related beta-carbolines, norharman and harman, shows the family can form DNA-damaging products under UV light. Nobody has tested 9-Me-BC specifically for this, but the community’s own harm-reduction rule, avoid sunlight during a cycle, tells you how seriously people take it. A compound where the standard advice includes “stay out of the sun” deserves scrutiny.

What the research shows

No human trials. Zero. Everything below is animal or in-vitro work. Read it as “interesting,” not “evidence it works in you.”

No human trial, no human pharmacokinetics, no human safety study. Everything here is cell cultures and one rat paper:

In rats, 10 days of 9-Me-BC treatment improved spatial learning in the radial maze, elevated hippocampal dopamine, and produced more complex dendritic trees in the hippocampus. Five days of treatment did not.J Neurochem 2012 · rat study

In primary dopaminergic cultures, 9-Me-BC stimulated dopamine neuron outgrowth, protected against toxins, and produced pronounced regeneration after chronic rotenone damage.J Neurochem 2010 · cell culture

In astrocyte cultures, 9-Me-BC inhibited MAO-A with an IC50 of 1 micromolar and MAO-B at 15.5 micromolar, and stimulated expression of neurotrophic factor genes including BDNF.J Neural Transm 2020 · cell culture

No human clinical trial or pharmacokinetic study of 9-Me-BC exists in the PubMed corpus.as of Aug 2026

Realistic protocols

I’m not building a dosing protocol from cell cultures and one rat study, especially not one where the compound class raises DNA-damage questions. For the record: the community runs 5 to 30 mg orally, most commonly around 15 to 20 mg, in short cycles of two to four weeks. People avoid sun exposure during the cycle because of the beta-carboline photosensitivity concern. If you run it anyway, go low, go short, stay out of the sun, and log everything.

Side effects

No human side-effect data exists. This is community reporting only:

anecdotalVivid dreams and disrupted sleep, reported consistently enough to be a pattern.

anecdotalMild stimulation and mood lift in the first days.

unknownBeta-carbolines can form genotoxic photoproducts under UV light. Nobody has tested this in humans with 9-Me-BC. The structural concern is real, and the absence of data is not reassurance.